Compare Ambarella Inc (AMBA) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ambarella Inc vs Sana Biotechnology Inc — how do they compare? Ambarella Inc trades at $83.47 (market cap $3.64B), while Sana Biotechnology Inc trades at $3.77 (market cap $1.13B). The key difference: Ambarella Inc is far larger — about 3.2× Sana Biotechnology Inc's market cap, and Ambarella Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| AMBA | SANA | |
|---|---|---|
Market Cap | $3.64B | $1.13B |
Sector | Technology | Health |
52-Week High | $95.51 | $5.92 |
52-Week Low | $48.65 | $2.68 |
Enterprise Value | $3.37B | $1.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ambarella (AMBA) trades at $83.48, up 1.76% with a bullish technical signal. Recent earnings beats and a strong analyst consensus support momentum. Revenue growth is projected from $285M in 2025 to $405M in 2026, though net losses persist. News highlights include potential acquisition talks with NXP and optimism around edge AI chips.
Outlook is positive with a $108.67 price target, but risks include sustained losses and competitive pressures. The stock's edge AI focus offers growth potential, yet profitability challenges and market volatility warrant caution for investors.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ambarella Inc
Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.
Read more on AMBA →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
